Skip to main content
. Author manuscript; available in PMC: 2024 Feb 1.
Published in final edited form as: Epilepsy Behav. 2023 Jan 10;139:109069. doi: 10.1016/j.yebeh.2022.109069

Table 1:

Participant characteristics for the confirmatory factor analysis (CFA; n=152) and reliability (test-retest; n=56) studies

Confirmatory Factor Analysis Sample n (%) Reliability Sample n (%)
Mutation Group
No functional protein 40 (26.32) 14 (25)
Missense/in-frame within the catalytic domain 43 (28.29) 19 (33.93)
Truncations between aa172 and aa781 40 (26.32) 13 (23.21)
Truncation after aa781 21 (13.82) 6 (10.71)
Not grouped 8 (5.26) 4 (7.14)
Country of residence
Australia or New Zealand 15 (9.87) 5 (8.93)
Europe 29 (19.08) 4 (7.14)
North America 89 (58.55) 44 (78.57)
UK 10 (6.58) 2 (3.57)
Other* 9 (5.92) 1 (1.79)
Gender
Male 27 (17.76) 11 (19.64)
Female 125 (82.24) 45 (80.36)
Age
3-11 93 (61.18) 30 (53.57)
12+ 59 (38.82) 26 (46.43)
Walking ability
Unable 101 (66.45) 33 (58.93)
Moderate assistance 9 (5.92) 6 (10.71)
Minimal assistance 6 (3.95) 1 (1.79)
No assistance 36 (23.68) 16 (28.57)
Communication
Simple/no communication 32 (21.05) 10 (17.86)
Gestures, signs or vocalisations 93 (61.18) 36 (64.29)
Words 27 (17.76) 10 (17.86)
QI-Disabilitya Confirmatory Factor Analysis Sample
Mean (SD) Median (min,max) Skew
Physical Health  74.4 (17.3) 75 (8.3,100) −0.76
Positive Emotions  64.5 (23.2) 68.8 (0,100) −0.41
Negative Emotions  73.9 (17.4) 75 (25,100) −0.95
Social Interactions  50.0 (27.3) 50 (0,100) 0
Leisure and the Outdoors  60.9 (27.1) 70 (0,100) −0.50
Independence  29.9 (24.6) 25 (0,95) 0.66
Total Score  58.9 (16.1) 58.3 (19.6,96.8) −0.11
a

Total possible scores out of 100

*

Includes Brazil, India, Russia, Saudi Arabia, Turkey, United Arab Emirates